Author

Hilary E. Hendin

Observed names: Hendin, Hilary, Hilary E. Hendin, Hilary Hendin

Institutions: Medicago (Canada), Research Institute of the McGill University Health Centre

Observed institutions: McGill University Health Centre, Medicago (Canada), Research Institute of the McGill University Health Centre, McGill University

ORCID: 0000-0002-0205-5692

Observed ORCID: 0000-0002-0205-5692

OpenAlex ID: A5063014588

Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro

2017 · Hilary E. Hendin, Stéphane Pillet, et al. · Vaccine · 31

Needle-free delivery of influenza vaccine using the Med-Jet® H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial

2019 · Janna R. Shapiro, Breanna Hodgins, et al. · Vaccine · 22

Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity

2022 · Hilary E. Hendin, Pierre-Olivier Lavoie, et al. · npj Vaccines · 19

Development and characterization of a plant-derived norovirus-like particle vaccine

2023 · Janna R. Shapiro, Guadalupe Andreani, et al. · Vaccine · 8

A Hemagglutinin 1 Carrying Plant-Based Virus-like Particle Vaccine Generates an Efficacious Cellular Response by Exploiting IL-1 Signaling in Both Adult and Aged Mice

2022 · Fernando Alvarez, Roman Istomine, et al. · ImmunoHorizons · 6

Marked Reduction in Viral Load and Symptoms in Breakthrough COVID-19 Cases Following AS03-Adjuvanted Plant-Made VLP Vaccination

2023 · Hilary E. Hendin, Alexander Makarkov, et al. · SSRN Electronic Journal

Works count: 7

Citation count: 86

H-index: 5

I10-index: 3